» Articles » PMID: 12393463

Identification of Distal Regulatory Regions in the Human Alpha IIb Gene Locus Necessary for Consistent, High-level Megakaryocyte Expression

Overview
Journal Blood
Publisher Elsevier
Specialty Hematology
Date 2002 Oct 24
PMID 12393463
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

The alphaIIb/beta3-integrin receptor is present at high levels only in megakaryocytes and platelets. Its presence on platelets is critical for hemostasis. The tissue-specific nature of this receptor's expression is secondary to the restricted expression of alphaIIb, and studies of the alphaIIb proximal promoter have served as a model of a megakaryocyte-specific promoter. We have examined the alphaIIb gene locus for distal regulatory elements. Sequence comparison between the human (h) and murine (m) alphaIIb loci revealed high levels of conservation at intergenic regions both 5' and 3' to the alphaIIb gene. Additionally, deoxyribonuclease (DNase) I sensitivity mapping defined tissue-specific hypersensitive (HS) sites that coincide, in part, with these conserved regions. Transgenic mice containing various lengths of the h(alpha)IIb gene locus, which included or excluded the various conserved/HS regions, demonstrated that the proximal promoter was sufficient for tissue specificity, but that a region 2.5 to 7.1 kb upstream of the h(alpha)IIb gene was necessary for consistent expression. Another region 2.2 to 7.4 kb downstream of the gene enhanced expression 1000-fold and led to levels of h(alpha)IIb mRNA that were about 30% of the native m(alpha)IIb mRNA level. These constructs also resulted in detectable h(alpha)IIb/m(beta)3 on the platelet surface. This work not only confirms the importance of the proximal promoter of the alphaIIb gene for tissue specificity, but also characterizes the distal organization of the alphaIIb gene locus and provides an initial localization of 2 important regulatory regions needed for the expression of the alphaIIb gene at high levels during megakaryopoiesis.

Citing Articles

Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A.

Lyde R, Ahn H, Vo K, Jarocha D, Tkaczynski J, Treffeisen E Blood Adv. 2019; 3(9):1368-1378.

PMID: 31036722 PMC: 6517653. DOI: 10.1182/bloodadvances.2017007914.


Phosphatidylinositol transfer proteins regulate megakaryocyte TGF-β1 secretion and hematopoiesis in mice.

Capitano M, Zhao L, Cooper S, Thorsheim C, Suzuki A, Huang X Blood. 2018; 132(10):1027-1038.

PMID: 30042096 PMC: 6128088. DOI: 10.1182/blood-2017-09-806257.


A chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation.

Fuentes R, Zaitsev S, Ahn H, Hayes V, Kowalska M, Lambert M J Clin Invest. 2015; 126(2):483-94.

PMID: 26690701 PMC: 4731161. DOI: 10.1172/JCI81470.


Intramedullary megakaryocytes internalize released platelet factor 4 and store it in alpha granules.

Lambert M, Meng R, Xiao L, Harper D, Marks M, Kowalska M J Thromb Haemost. 2015; 13(10):1888-99.

PMID: 26256688 PMC: 4638179. DOI: 10.1111/jth.13069.


Inducible Gata1 suppression expands megakaryocyte-erythroid progenitors from embryonic stem cells.

Noh J, Gandre-Babbe S, Wang Y, Hayes V, Yao Y, Gadue P J Clin Invest. 2015; 125(6):2369-74.

PMID: 25961454 PMC: 4497743. DOI: 10.1172/JCI77670.